+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cardiomyopathy"

From
From
Global Perfusion Imaging Market - Product Thumbnail Image

Global Perfusion Imaging Market

  • Report
  • May 2024
  • 200 Pages
From
Cardiomyopathies Epidemiology Forecast, 2021-2031 - Product Thumbnail Image

Cardiomyopathies Epidemiology Forecast, 2021-2031

  • Report
  • June 2022
  • 38 Pages
  • Global
From
From
Disease Analysis: Chronic Heart Failure - Product Thumbnail Image

Disease Analysis: Chronic Heart Failure

  • Report
  • March 2021
  • 98 Pages
  • Global
Perinatal Cardiology Part 2 - Product Thumbnail Image

Perinatal Cardiology Part 2

  • Book
  • July 2020
From
Heart Failure in Pediatric Patients - Product Thumbnail Image

Heart Failure in Pediatric Patients

  • Book
  • January 2020
  • 207 Pages
From
From
Genetic Cardiomyopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Genetic Cardiomyopathies Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 200 Pages
  • Global
From
From
Cardiology at its Core. Edition No. 1 - Product Thumbnail Image

Cardiology at its Core. Edition No. 1

  • Book
  • May 2023
  • 272 Pages
Cardiology Board Review. Edition No. 2 - Product Thumbnail Image

Cardiology Board Review. Edition No. 2

  • Book
  • April 2023
  • 688 Pages
Mastering Structural Heart Disease. Edition No. 1 - Product Thumbnail Image

Mastering Structural Heart Disease. Edition No. 1

  • Book
  • February 2023
  • 672 Pages
Loading Indicator

Cardiomyopathy is a group of diseases that affect the heart muscle. It is a leading cause of heart failure and can lead to arrhythmias, stroke, and sudden cardiac death. Symptoms of cardiomyopathy can include shortness of breath, chest pain, fatigue, and swelling of the legs and feet. Treatment options vary depending on the type of cardiomyopathy, but may include lifestyle changes, medications, and surgery. The cardiomyopathy market is a rapidly growing segment of the cardiology industry. It is driven by the increasing prevalence of cardiomyopathy, advances in medical technology, and the development of new treatments. Companies in this market are focused on developing treatments and therapies to improve the quality of life for those affected by cardiomyopathy. Some companies in the cardiomyopathy market include Novartis, Pfizer, Sanofi, and AstraZeneca. These companies are developing treatments and therapies to improve the quality of life for those affected by cardiomyopathy. Additionally, there are many smaller companies and startups that are focused on developing innovative treatments and therapies for cardiomyopathy. Show Less Read more